| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.03. | Barclays raises Lifestance Health stock price target on growth outlook | 12 | Investing.com | ||
| 02.03. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 26.02. | 6 Analysts Assess LifeStance Health Gr: What You Need To Know | 1 | Benzinga.com | ||
| 26.02. | KeyBanc raises Lifestance Health stock price target on productivity | 1 | Investing.com | ||
| 26.02. | Lifestance outlines $1.615B-$1.655B 2026 revenue target while advancing AI, EHR initiatives and $100M buyback | 3 | Seeking Alpha | ||
| 25.02. | LifeStance stockholders plan 25M share offering | 1 | Investing.com | ||
| 25.02. | LifeStance: Aktionäre planen Verkauf von 25 Millionen Aktien | 1 | Investing.com Deutsch | ||
| 25.02. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 25.02. | LifeStance Health Group, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 25.02. | LifeStance Health Group, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 25.02. | LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% | 1 | Investing.com | ||
| 25.02. | Earnings Summary: LifeStance Health Gr Q4 | 1 | Benzinga.com | ||
| 25.02. | LifeStance Health Group reports Q4 results; introduces FY26 outlook | 1 | Seeking Alpha | ||
| 25.02. | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | 370 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 24.02. | Lifestance Health vor Quartalszahlen: Weg zur Profitabilität im Fokus | 1 | Investing.com Deutsch | ||
| 02.02. | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) | 2 | Benzinga.com | ||
| 22.01. | Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes | 1 | Insider Monkey | ||
| 08.11.25 | LifeStance (LFST) Soars 30% on Q3 Earnings Blowout | 1 | Insider Monkey | ||
| 06.11.25 | Lifestance anticipates mid-teens revenue growth for 2026 while raising adjusted EBITDA guidance amid record productivity gains | 6 | Seeking Alpha | ||
| 06.11.25 | LifeStance Health Group, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,480 | +0,70 % | PRESSESPIEGEL/Unternehmen: COMMERZBANK, DEUTSCHE BANK, FRESENIUS, DEUTSCHE BAHN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
COMMERZBANK - Der Commerzbank-Betriebsrat verschärft im Übernahmekampf... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,290 | +0,92 % | EQS-DD: Fresenius Medical Care AG: Helen Pring Giza, Kauf von Aktien unter dem Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Zuteilung 2023) | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.03.2026 / 09:28... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 36,790 | +0,22 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 24,900 | +3,92 % | Ihre wichtigsten Termine: Spannende Updates von: Fedex, Continental, Docmorris, Carl Zeiss Meditec und 1&1 | © Foto: Kevin Wolf - FR33460 APGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| TELADOC HEALTH | 4,804 | +2,18 % | Teladoc Health Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Teladoc Health, Inc. (TDOC) on Wednesday reported a fourth-quarter net loss of $25.1 million, or $0.14 per share, compared to $48.4 million or $0.28 per share last year.Fourth-quarter... ► Artikel lesen | |
| ROKU | 84,06 | +1,68 % | Aurzen Official: Aurzen Announces Big Spring Sale for Aurzen Roku TV Smart Projectors | Designed to simplify both performance and usability, with a built-in Roku TV OS, Aurzen Roku TV Smart Projectors allow users to access thousands of streaming channels and apps instantly-without external... ► Artikel lesen | |
| DEXCOM | 57,47 | -0,76 % | Evercore ISI upgrades DexCom stock rating on growth outlook | ||
| INMODE | 11,860 | +0,55 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| PETMED EXPRESS | 1,874 | -0,48 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| ORGANON | 5,256 | -0,57 % | Organon sees opportunities in China's push for high-quality population development | ||
| TANDEM DIABETES | 20,680 | -1,24 % | Truist upgrades Tandem Diabetes Care stock rating on Pay/Go model | ||
| INSULET | 191,95 | -0,88 % | Is Insulet Stock Underperforming the Dow? | ||
| MOLINA HEALTHCARE | 119,40 | -2,41 % | MOLINA HEALTHCARE INC - Stabilität im Fokus | ||
| QUIDELORTHO | 14,100 | +0,71 % | QuidelOrtho Corporation: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer | SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 1,553 | -1,43 % | Clover Health Investments, Corp.: Primary Care Physician Use of Counterpart Assistant Associated with 18%-22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients |